[artículo] 
inEuropean Neuropsychopharmacology > Año 2016 - Vol. 26 - No.2 (Febrero) . - pp. 310-319

Título :	Prazosin addition to fluvoxamine : A preclinical study and open clinical trial in OCD
Tipo de documento:	texto impreso
Autores:	Matthijs G.P. Feenstra, Autor ; André A. Klompmakers, Autor ; Martijn Figee, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 310-319
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Dopamina, Serotonina, Corteza prefrontal, Aumento, Trastorno obsesivo compulsivo
Resumen:	The efficacy of selective serotonin reuptake inhibitors (SRIs) in psychiatric disorders may be “augmented” through the addition of atypical antipsychotic drugs. A synergistic increase in dopamine (DA) release in the prefrontal cortex has been suggested to underlie this augmentation effect, though the mechanism of action is not clear yet.
Link:	./index.php?lvl=notice_display&id=26612

[artículo] Prazosin addition to fluvoxamine : A preclinical study and open clinical trial in OCD [texto impreso] / Matthijs G.P. Feenstra, Autor ; André A. Klompmakers, Autor ; Martijn Figee, Autor . - 2021 . - pp. 310-319.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No.2 (Febrero) . - pp. 310-319

Palabras clave:	Dopamina, Serotonina, Corteza prefrontal, Aumento, Trastorno obsesivo compulsivo
Resumen:	The efficacy of selective serotonin reuptake inhibitors (SRIs) in psychiatric disorders may be “augmented” through the addition of atypical antipsychotic drugs. A synergistic increase in dopamine (DA) release in the prefrontal cortex has been suggested to underlie this augmentation effect, though the mechanism of action is not clear yet.
Link:	./index.php?lvl=notice_display&id=26612